A NAD+ 1000mg & Retatrutide: A UK Innovation in Physiological Wellbeing
Emerging data from the UK are generating considerable interest surrounding 000mg the potential synergy of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This unusual approach aims to target multiple facets of m